Home

Venus Remedies Ltd EPS

Image

Venus Remedies Ltd

NSE: VENUSREM

EPS

₹ 20.85

Last updated on: Feb 21, 2025

Key Highlights

  • The Earning per Share of Venus Remedies Ltd is ₹ 20.85 as of 21 Feb 25 .
  • The earning per share of Venus Remedies Ltd changed from ₹ 0.88 to ₹ 14.66 over 7 quarters. This represents a CAGR of 398.98% .

Historical Earning per Share of Venus Remedies Ltd

No data available

* All values are in

Company Fundamentals for Venus Remedies Ltd

Market Cap

413 Cr

EPS

20.9

P/E Ratio (TTM)

14.9

P/B Ratio (TTM)

0.8

Day’s High

317.3

Day’s Low

309.5

DTE

0.1

ROE

4.5

52 Week High

427.3

52 Week Low

272.2

ROCE

7.7

Market Price of Venus Remedies Ltd

1M

1Y

3Y

5Y

Monitoring Venus Remedies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 2025309.65
20 Feb 2025313
19 Feb 2025307.55
18 Feb 2025304.45
17 Feb 2025306.35
14 Feb 2025317.45
13 Feb 2025316.05
12 Feb 2025321.5
11 Feb 2025313.7
10 Feb 2025356.9

SWOT Analysis Of Venus Remedies Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Venus Remedies Ltd

Asset Value vs Market Value of Venus Remedies Ltd

Market Value

414

Asset Value

Value addition

0.2 X

358

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Venus Remedies Ltd413.91
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

Historical Market Cap of Venus Remedies Ltd

No data available

* All values are in crore

Historical Revenue of Venus Remedies Ltd

No data available

* All values are in crore

Historical EBITDA of Venus Remedies Ltd

No data available

* All values are in crore

Historical Net Profit of Venus Remedies Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Venus Remedies Ltd News Hub

Venus Remedies consolidated net profit rises 3.39% in the June 2024 quarter

Net profit of Venus Remedies rose 3.39% to Rs 1.22 crore in the quarter ended June 2024 as against R

Read more

14 Aug 24

Venus Remedies to discuss results

Venus Remedies will hold a meeting of the Board of Directors of the Company on 13 August 2024. Power

Read more

03 Aug 24

Venus Remedies AGM scheduled

Venus Remedies announced that the 35th Annual General Meeting (AGM) of the company will be held on 2

Read more

24 Aug 24

Venus Remedies to table results

Venus Remedies will hold a meeting of the Board of Directors of the Company on 29 October 2024. Powe

Read more

18 Oct 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Venus Remedies Ltd

What is the EPS of Venus Remedies Ltd stock?

The Earnings Per Share (EPS) of Venus Remedies Ltd is 20.85. An EPS is the amount of net income attributed to each share of a common stock.

How is Venus Remedies Ltd EPS calculated?

The EPS of Venus Remedies Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Venus Remedies Ltd report its EPS?

Venus Remedies Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Venus Remedies Ltd EPS?

Factors that influence the EPS of Venus Remedies Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Venus Remedies Ltd EPS growth indicate future performance?

Yes, consistent growth in Venus Remedies Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions